WHO backs use of GLP-1 drugs for weight loss, along with diet, exercise
WHO guidelines say GLP-1 drugs are effective as long-term treatment for obesity in adults, barring pregnant women, alongside diet, exercise interventions; call for equitable access to reduce global obesity costs…
Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a semaglutide injection 2.4 mg for weight loss, the statement said. New Delhi: Novo…
Weight loss drug ‘Ozempic’ approved for use in India: What we need to know about its health benefits and risks
India has officially approved the use of Ozempic (semaglutide), a once-a-week injection designed for adults with type 2 diabetes. Approved by the Central Drugs Standard Control Organisation (CDSCO), this drug…
Dr Reddy’s gears up for weight loss drug study
Dr Reddy’s Laboratories has got a go-head from the Subject Expert Committee (SEC) under India’s drug regulatory authority to conduct a bioequivalence study required to establish the safety and efficacy of the blockbuster weight…
